Search Page

1

Cite

Share

Hypnosis.

Phillips W, Price J, Molyneux PD, Deeley Q. Phillips W, et al. Among authors: molyneux pd. Pract Neurol. 2022 Feb;22(1):42-47. doi: 10.1136/practneurol-2020-002839. Epub 2021 Aug 13. Pract Neurol. 2022. PMID: 34389642

Cite

Share

2

Cite

Share

Beyond PPE: a mixed qualitative-quantitative study capturing the wider issues affecting doctors' well-being during the COVID-19 pandemic.

Cubitt LJ, Im YR, Scott CJ, Jeynes LC, Molyneux PD. Cubitt LJ, et al. Among authors: molyneux pd. BMJ Open. 2021 Mar 22;11(3):e050223. doi: 10.1136/bmjopen-2021-050223. BMJ Open. 2021. PMID: 33753449 Free PMC article.

Cite

Share

3

Cite

Share

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH. Molyneux PD, et al. Ann Neurol. 1998 Mar;43(3):332-9. doi: 10.1002/ana.410430311. Ann Neurol. 1998. PMID: 9506550 Review.

Cite

Share

4

Cite

Share

Migraine, an open and shut case?

Molyneux PD, Jordan K. Molyneux PD, et al. Pract Neurol. 2010 Jun;10(3):172-5. doi: 10.1136/jnnp.2010.212704. Pract Neurol. 2010. PMID: 20498194 No abstract available.

Cite

Share

5

Cite

Share

Decoding neuronal ensembles in the human hippocampus.

Hassabis D, Chu C, Rees G, Weiskopf N, Molyneux PD, Maguire EA. Hassabis D, et al. Among authors: molyneux pd. Curr Biol. 2009 Apr 14;19(7):546-54. doi: 10.1016/j.cub.2009.02.033. Epub 2009 Mar 12. Curr Biol. 2009. PMID: 19285400 Free PMC article.

Cite

Share

6

Cite

Share

Tricyclic antidepressants reduce frequency of tension-type and migraine headaches compared with placebo, and intensity of headaches compared with SSRIs, but cause greater adverse effects.

Molyneux PD. Molyneux PD. Evid Based Med. 2011 Jun;16(3):75-6. doi: 10.1136/ebm1176. Epub 2011 Jan 19. Evid Based Med. 2011. PMID: 21252162 No abstract available.

Cite

Share

7

Cite

Share

Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations.

Kelly JA, Molyneux PD, Smith SA, Smith SE. Kelly JA, et al. Among authors: molyneux pd. Br J Ophthalmol. 1989 May;73(5):360-2. doi: 10.1136/bjo.73.5.360. Br J Ophthalmol. 1989. PMID: 2730857 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.

Brex PA, Molyneux PD, Smiddy P, Barkhof F, Filippi M, Yousry TA, Hahn D, Rolland Y, Salonen O, Pozzilli C, Polman CH, Thompson AJ, Kappos L, Miller DH; European Study Group on Interferon beta-1b in Secondary Progressive MS. Brex PA, et al. Among authors: molyneux pd. Neurology. 2001 Dec 26;57(12):2185-90. doi: 10.1212/wnl.57.12.2185. Neurology. 2001. PMID: 11756595 Clinical Trial.

Cite

Share

9

Cite

Share

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

Brex PA, Gomez-Anson B, Parker GJ, Molyneux PD, Miszkiel KA, Barker GJ, MacManus DG, Davie CA, Plant GT, Miller DH. Brex PA, et al. Among authors: molyneux pd. J Neurol Sci. 1999 Jun 15;166(1):16-22. doi: 10.1016/s0022-510x(99)00105-7. J Neurol Sci. 1999. PMID: 10465494

Cite

Share

10

Cite

Share

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS. Molyneux PD, et al. Neurology. 2001 Dec 26;57(12):2191-7. doi: 10.1212/wnl.57.12.2191. Neurology. 2001. PMID: 11756596 Clinical Trial.

Cite

Share